Tissue Regenix Group (TRX) Competitors GBX 8.75 -0.38 (-4.11%) As of 11:34 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock TRX vs. NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, WPM, and IAGShould you be buying Tissue Regenix Group stock or one of its competitors? The main competitors of Tissue Regenix Group include Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), Wheaton Precious Metals (WPM), and International Consolidated Airlines Group (IAG). These companies are all part of the "precious metals" industry. Tissue Regenix Group vs. Its Competitors Nakama Group plc (NAK.L) (EGI.L) 532753 (IMG.L) 651814 (EDG.L) ArcelorMittal Nature Group Randgold Resources National Grid Wheaton Precious Metals International Consolidated Airlines Group Nakama Group plc (NAK.L) (LON:NAK) and Tissue Regenix Group (LON:TRX) are both small-cap precious metals companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment. Which has higher valuation and earnings, NAK or TRX? Nakama Group plc (NAK.L) has higher earnings, but lower revenue than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Nakama Group plc (NAK.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNakama Group plc (NAK.L)£8.09M0.00N/A-£0.20N/ATissue Regenix Group£27.75M0.22-£1.11M-£0.02-458.12 Does the media favor NAK or TRX? In the previous week, Nakama Group plc (NAK.L)'s average media sentiment score of 0.00 equaled Tissue Regenix Group'saverage media sentiment score. Company Overall Sentiment Nakama Group plc (NAK.L) Neutral Tissue Regenix Group Neutral Do institutionals & insiders believe in NAK or TRX? 0.0% of Tissue Regenix Group shares are held by institutional investors. 6.9% of Tissue Regenix Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is NAK or TRX more profitable? Nakama Group plc (NAK.L) has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -3.46%. Nakama Group plc (NAK.L)'s return on equity of 0.00% beat Tissue Regenix Group's return on equity.Company Net Margins Return on Equity Return on Assets Nakama Group plc (NAK.L)N/A N/A N/A Tissue Regenix Group -3.46%-2.87%0.50% SummaryTissue Regenix Group beats Nakama Group plc (NAK.L) on 5 of the 8 factors compared between the two stocks. Get Tissue Regenix Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart TRX vs. The Competition Export to ExcelMetricTissue Regenix GroupBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£6.23M£231.75M£9.05B£2.61BDividend Yield4.12%3.80%5.69%5.28%P/E Ratio-458.1296.9485.844,440.52Price / Sales0.226,073.88535.76100,568.44Price / Cash5.7013.1937.9227.90Price / Book0.21113.4713.058.88Net Income-£1.11M-£90.99M£3.30B£5.89B7 Day Performance-16.67%3.98%4.81%0.81%1 Month Performance-65.00%6.29%9.99%5.86%1 Year Performance-83.61%725.82%85.26%154.98% Tissue Regenix Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRXTissue Regenix GroupN/AGBX 8.75-4.1%N/A-83.4%£6.23M£27.75M-458.12120High Trading VolumeNAKNakama Group plc (NAK.L)N/AN/AN/AN/A£1.44M£8.09M-6.1353Gap DownHigh Trading VolumeEGI(EGI.L)N/AN/AN/AN/A£0.00N/A0.006Gap DownHigh Trading VolumeIMG532753 (IMG.L)N/AN/AN/AN/A£0.00N/A0.005,360High Trading VolumeEDG651814 (EDG.L)N/AN/AN/AN/A£0.00N/A0.002,610MTAArcelorMittalN/AN/AN/AN/A£0.00N/A0.009News CoveragePositive NewsHigh Trading VolumeNGRNature GroupN/AN/AN/AN/A£0.00N/A0.0010Gap UpRRSRandgold ResourcesN/AN/AN/AN/A£0.00N/A0.0021,300Gap UpNGNational Grid1.4731 of 5 starsGBX 1,070-0.5%GBX 1,070+10.2%£52.53B£25.99B17.5810High Trading VolumeWPMWheaton Precious Metals2.3922 of 5 starsGBX 8,172.79+3.7%GBX 8,300+1.6%+78.8%£37.10B£1.66B4,707.8342News CoveragePositive NewsAnalyst ForecastGap DownIAGInternational Consolidated Airlines Group1.1556 of 5 starsGBX 385.80-0.2%GBX 403.33+4.5%+102.2%£17.85B£33.28B597.215,360 Related Companies and Tools Related Companies NAK Competitors EGI Competitors IMG Competitors EDG Competitors MTA Competitors NGR Competitors RRS Competitors NG Competitors WPM Competitors IAG Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TRX) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
